Tag: Chorea

Affecting one in four patients taking certain antipsychotic medications, tardive dyskinesia is a significant movement disorder [1.8.3]. So, **what type of drug is deutetrabenazine?** It is a vesicular monoamine transporter 2 (VMAT2) inhibitor used to manage this and other movement disorders [1.2.1].

First approved by the FDA in 2008 as the first drug specifically for a symptom of Huntington's disease, tetrabenazine was a landmark treatment. So, what does tetrabenazine treat, and how does it manage the involuntary movements associated with certain neurological conditions?